Investor Relations

BioBT | Investor Relations

Investing in the Future of Medical Technology

Innovated in India. Designed for Global Healthcare.

BioBT is an Indian medical technology company developing advanced diagnostic systems that combine biomedical engineering, intelligent software, and innovative hardware solutions.

We are building a scalable, multi-product medical technology business focused on making advanced healthcare diagnostics more accessible and affordable.

One Company. Multiple Technologies. A Growing Healthcare Opportunity.

Our Flagship Innovation

SpiroBT Vmax

Cardiopulmonary Exercise Testing (CPET)

Advanced Cardiopulmonary Diagnostics. Engineered in India.

Our flagship CPET platform brings together respiratory gas analysis, exercise physiology, and intelligent diagnostic software to support advanced cardiopulmonary assessment.

Designed for cardiology, pulmonology, sports medicine, and medical research, SpiroBT Vmax represents a key opportunity in BioBT's next phase of innovation and growth.

A Diversified Medical Technology Portfolio

Six Product Platforms. Multiple Healthcare Specialties.

TechnologyDiagnostic Focus
SpiroBT VmaxCardiopulmonary Exercise Testing
HolterSyncAmbulatory Cardiac Monitoring
SpiroBTPulmonary Function Testing
NeuroBTEEG & Neurophysiology
BlueBTECG & Heart Rate Variability
PhysioBTPhysiological Data Acquisition

From cardiology to respiratory care and neuroscience, our technologies create opportunities across hospitals, medical colleges, diagnostic centers, and research institutions.

Partner With Us in Our Next Growth Phase

Building Technology. Creating Value. Advancing Healthcare.

BioBT welcomes strategic investors and partners who share our vision of building a globally competitive Indian medical technology company.

Discover the opportunity behind our technology portfolio.

Request Private Investor Presentation Connect With Our Leadership Team

Detailed business plans, financial information, technology roadmaps, and investment proposals are available to qualified investors upon discussion.

Why BioBT?

Indigenous Innovation – In-house biomedical hardware and software development.

Diversified Portfolio – Multiple diagnostic technologies serving different healthcare segments.

Scalable Opportunity – A platform-driven approach to product development and manufacturing.

Global Vision – Indian engineering with ambitions for international healthcare markets.